Search

everythinglearnresearchcommunity

for

Search:↓

Scalp cooling to prevent hair loss from chemotherapy works for some but not all, and studying hair damage markers could improve prevention and treatment.

Gray hair can potentially be reversed, leading to new treatments.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

Tadalafil and Finasteride may help treat aggressive melanoma.

Leflunomide is more likely to help treat alopecia areata than cause it.

Propylthiouracil can cause hair loss, reduced sweating, and nail issues, but stopping the drug can reverse hair and nail problems.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

The girl's regrown brown hair had less of certain pigments than her original black hair.

The health of the gut may be important in developing new ways to prevent, diagnose, and treat alopecia areata.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

CIP/KIP proteins help stop cell division and support hair growth.

Case-only trees and random forests improve predictions of treatment effects in clinical trials.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

Ultrasound is a useful, non-invasive tool in dermatology for diagnosing skin conditions and guiding treatments, but it has some limitations.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

The document concludes that computational models are useful for understanding immune responses and could improve cancer immunotherapy.

An emollient PLUS balm with ADE-G1 significantly improved skin dryness and quality of life in cancer patients with xerosis.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.